Testing effectiveness (Phase 2)UnknownNCT03767322
What this trial is testing
Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
Who this might be right for
Contrast-induced NephropathyContrast-induced Acute Kidney Injury
Instituto Nacional de Cardiologia Ignacio Chavez 558